Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Basiliximab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Temozolomide 45 Bevacizumab 27 Erlotinib Hydrochloride 15 Carmustine 15 Irinotecan 13 Radiotherapy 12 Imatinib Mesylate 10 Carboplatin 10 Surgical Procedures, Operative 9 O(6)-benzylguanine 8 Filgrastim 8 sargramostim 7 Sirolimus 7 Procarbazine 7 Etoposide 7 Cyclophosphamide 7 Thalidomide 6 Sorafenib 6 Radiosurgery 6 Radiation 6 temsirolimus 5 Topotecan 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Magnetic Resonance Spectroscopy 5 Hydroxyurea 5 Gefitinib 5 Everolimus 5 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5 etoposide phosphate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00626483 2021-03-09

REGULATe

Duke University

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡